chrisvoncsefalvay/vaers-outcomes huggingface dataset:
hungry; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HUNGER (non-serious), outcome "unknown", described as "hungry".  Additional Information: Investigation assessment not provided. The reporter confirmed her friend told her that she was hungry after her COVID shot also.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Severe Headache within first grade lasting 3 days. Nausea. Severe joint pain. Severe muscle cramps in back of both legs. Chills started at 9 pm ended at midnight when fever started. Midnight 99.2, one am 101.3. Two am 102.1. Fever broke 24 hrs later around midnight 4/17/2021. Headache and joint pain ended 4/18/2021.
3 hours post injections high fever of 102.6, unrelieved by tylenol or motrin. Fever continued x 3.5 days. Child lethargic, eyes swollen, not herself. loose stools x 5 days. On day 5 post injection child covered on entire torso with raised red rash, child screams if touched. Behavior is different, child now having tantrums and throwing herself backwards, screaming constantly and yelping a high pitched screech. Alerted family Dr. and treated with motrin and tepid baths.
Patient presented to the emergency department at Hospital with headaches and paresthesia (bilateral lower extremities). Over a short period of time, he developed worsening weakness, diminishing NIF (negative inspiratory force), ataxic gait and was diagnosed with Guillain-Barre syndrome (Miller Fisher variant). He was treated with IVIg and later underwent plasmapheresis due to severe weakness. He was intubated overnight and had some improvement in his respiratory mechanics the following day prompting extubation to BiPAP. He continues to be hospitalized in the PICU at Hospital at this time.
received vaccine after being exposed to covid, pharmacists failed to give patient consent form, patient passed out and woke up in ER, shortness of breath sore throat
First two days after vaccine patient had headache and chills, pain and discomfort in the arm, limited range of motion in the left arm.  In the two week since the vaccine patient had continued to have pain in the muscle, a small bump that shows up in the morning and goes away throughout the day and returns again then next morning.  Pain and discomfort in the arm, and limited range of motion.
Info has been received from a physician concerning a pregnant female who's brother was vaccinated with a dose of varicella virus vaccine live on 9/27/05. No reaction to the vaccine was reportedly experienced by the pt's brother, however, the pt had a "varicella titer" taken and it was IgM positive, indicating a recent exposure to varicella or active varicella. Medical attention was sought. It was reported that the pt had never received the varicella virus vaccine live and never had chickenpox. The pt was asymptomatic at the time of the report. There was no specific info given regarding the pt's pregnancy. No product quality complaint was involved. Follow-up info indicated that the pt was exposed to varicella by a family member that was vaccinated. No additional info was available. No additional info is expected.
Information has been received from a physician concerning a 31 day old male who on 24-FEB-2011 was vaccinated with a dose of VAQTA instead of hepatitis B virus vaccine. No adverse symptoms noted. The patient sought unspecified medical attention. This is one of the several reports from the same source. Additional information has been requested.
Tested positive for COVID 2 1/2 mos after vaccination.  Symptoms - fatigue, muscle aches, low grade fever <100, night sweats, cough, nasal congestion.  Tested negative after 2 weeks.  Saw doc for persistent cough after 2 weeks (on 1/6),  prescribed benzonatate.  said he'd give me inhaler if cough doesn't improve.
This is a spontaneous report received from a contactable consumer or other non-HCP (patient). A 65-year-old male patient received the 3rd (booster) dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, batch/lot# unknown), at the age of 65, single dose, for COVID-19 immunisation. Medical history and concomitant medications not reported. Vaccination history included 1st and 2nd dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine), for COVID-19 immunization. The patient had fatigue (became very tired), myalgia (muscle and joint aches), arthralgia, headache, photophobia (light sensitivity) and decreased appetite (no appetite), with outcome of unknown. This follow-up submitted to notify the batch/lot number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information expected.
swollen at the vaccination site; red spot at the vaccination site; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (swollen at the vaccination site) and VACCINATION SITE ERYTHEMA (red spot at the vaccination site) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939902) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE SWELLING (swollen at the vaccination site) and VACCINATION SITE ERYTHEMA (red spot at the vaccination site). At the time of the report, VACCINATION SITE SWELLING (swollen at the vaccination site) and VACCINATION SITE ERYTHEMA (red spot at the vaccination site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Relevant concomitant medications were not reported by reporter.  Treatment information was not provided by reporter.
Pt vax 25Mar91;  48 hrs after inj exp nausea, & chills.  Tx w/ phenergan.  Sx resolved.
Localized redness and swelling-hot to touch one hour post injection-swelling subsided by 11/18/02 arm is still tender on 11/18/02. Swollen glands on R side of neck on 11/18/02.
Sore arm, muscle aches mostly across my shoulders from side to side on my back, tired, no fever but woke up from a sleep totally drenched in sweat this was 1 day after shot.  on day 2 after shot I felt much better arm still a little sore and a litte tired but defently much better  Took tylenol and advil for the discomfort
My face on my cheeks on forehead and the sides of my head got very hot and red I took my temperature, but I did not have a fever. I called an after-hours clinic. They stated they thought it may be a mild allergenic reaction to the COVID-19 vaccine that I had gotten that day.  I began not feel well and had a mild headache with extreme fatigue. My lower belly and upper legs just felt like it was burning and on fire with muscle and joint pain, but my feet and hands were very cold. I was too tired to take my temperature during the night but when I woke up the next morning and I did have a fever.
This spontaneous report as received from a healthcare worker refers to multiple unspecified patients of unknown age and gender. The patients' concurrent conditions, medical history and concomitant medications were not reported. On unknown dates, the patients were vaccinated with improperly stored ROTATEQ (lot # K024700, expiry date 30-JUL-2016 (route and site of administration were not reported). No adverse effects were reported. The vaccines were exposed to 33.8 degrees Fahrenheit for 30 minutes. There was no previous temperature excursion noted. The call was placed because of data logger. This is one of two reports received from the same source. Additional information has been requested.
Pfizer-BioNTech COVID-19 Vaccine EUA  Fever up to 101.6 that lasted for 7 days, throbbing headache continuously for 8 days, severe back pain, chills
Swollen lymph nodes in breast and arm pit. Fever of 102. Chills, sweating, headache.
Pt after denying any issues with injections appeared to faint in chair. At no time did pt fall forward or to the side.  Pt alternating between following commands to open eyes with not responding  Pulse 80 to 100 and reg rhythm throughout, strong in quality.  When transferring pt to stretcher legs gave out but when chest thumb thrust applied pt pushed hand away and stood up to allow turn to stretcher.  Placed in O2 via nasal cannula at 2lpm.  Placed cold pac at base of neck and patient pushed it away also when applying rails pt pushed away from rails but unaable to grasps my fingers for strength check  Pupils equal and reacting to light in less than two minutes pt began to follow commands and open eyes.  Pt insistent upon driving self home " in a few hours." Pt quite upset son agrees with Dr and myself needs ED eval.Pt alternated with being unable to move lower extremities to moving feet on command.  Per son this is not unusual for pt to do this.  911 called pt to TOH alert and responding Oriented times three. Son with pt.  ED Dx: vasovagal episode with recurrent conversion disorder Patient refused admission, discharged home from ED
extremely bitter taste in mouth...persistent and has not gone away. Appeared a coiple of days after first shot and was present for second dose on 3/9/21.  Bitter taste..sensitive inside lips..roof of mouth. Nothing gets rid of it. vaccine has caused "Burning Mouth Syndrome" from some damage to the facial nerve. Did feel intense pain under ear 20 hours after second shot.....but bitterness had already manifested after first shot. Never had this issue ever and it makes eating and just "being" very challenging. People should know about this potential side effect. I researched thoroughly but never saw anything from vaccine  on this. Yet now informally have read of many other sufferers of this harsh and lasting side effect.
Patient noticed next day redness and swelling and soreness from injection site. Site described as left upper inner arm. Wednesday swelling and redness was enlarged. She come to pharmacy and showed me. I told her it looked infected and go see MD of clinic. She saw primary care MD who prescribed KEFLEX and MEDROL Dose Pack.
2nd dose is scheduled 19 days after the 1st dose; A spontaneous report was received from a non-health care professional concerning a male patient who received Moderna's COVID-19 Vaccine and 2nd dose is scheduled 19 days after the 1st dose (Inappropriate schedule of product administration).   The patient's medical history was not provided. Concomitant product use was not provided by the reporter.   On 15-Jan-2021, patient received their first of two planned doses of mRNA-1273.  Patient was scheduled for his Moderna vaccine 1st dose on 15-Jan-2021. His 2nd dose was scheduled on 02-Feb-2021, which is only 19 days after his first dose. The patient wants to know if this will affect the efficacy and safety of the vaccine.  Treatment information was not provided.   Action taken with mRNA-1273 in response to the event was not provided.   The outcome of the event 2nd dose is scheduled 19 days after the 1st dose was not reported.; Reporter's Comments: This report refers to a case of inappropriate schedule of product administration for mRNA-1273.  There were no reported adverse events associated with this case.
symptomatic COVID-19 after 3 doses of Moderna  pt SOB starting 12/28/21 1/3/22: pt test positive for COVID-19 (during this time pt was also seen for cranial aneurysm - presenting with slurred speech) pt had worsening symptoms of SOB and presented to ER on 1/31/21 (no treatment needed at that time and was given an albuterol inhaler) pt still experiencing shortness of breath as of 1/31/22
Information has been received from a registered nurse concerning that her son's several female friends developed muscle twitches and tingling sensations after receiving GARDASIL.  All drop down fields refer to all patients.  No further information is available at the time of reporting.  It's unspecified that the patients sought any medical attention.  No further information is available.
Employee states that area became reddened and itchy the night that she received the vaccine. She states that she washed area with warm soapy water twice.
Patient had a syncopal episode within 10 minutes of receiving his second Moderna dose. Patient states "I sat down with my phone in my lap and started to feel clammy and hot. The next thing I remember is waking up to the pharmacy staff surrounding me". Patient was seated, alert and oriented while waiting for emergency services. He was taken to the local hospital and received Zofran for his nausea in the ambulence. Patient states that he felt normal within 30 minutes.
cardiac injuries; Information has been received from a lawyer regarding a case in litigation, concerning a female patient (pt) of unknown age. The pt's medical history, concurrent conditions and concomitant medications were not reported.   On 17-MAY-2016, the pt was inoculated with zoster vaccine live (ZOSTAVAX) for routine health maintenance and for its intended purpose of prevention of shingles (herpes zoster) (dose, route of administration, anatomical location, lot number and expiration date were not reported).   On or about 22-MAY-2016, shortly after receiving the vaccine, the pt experienced cardiac injuries, including but not limited to hospitalization and extensive medical treatment. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the pt's symptoms resulted in physical limitations not present prior to using the vaccine. The pt also experienced mental and emotional distress due to resulting physical limitations and seriousness of her condition and had suffered economic losses due to her inability to work. Moreover, as a result of the manufacture, marketing, advertising, promotion, distribution and/or sale of zoster vaccine live (ZOSTAVAX), the pt sustained severe and disfiguring personal injuries and serious, progressive, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. The outcome of the event was not recovered.   The reporter considered that cardiac injuries were caused by zoster vaccine live (ZOSTAVAX).  Upon internal review, cardiac injuries was considered to be a medically significant and disabling event.
Information has been received from a 61 year old female patient with no drug reactions or allergies concerning herself. The patient's concurrent conditions included high blood pressure and osteoporosis. Concomitant therapies included unspecified "Routine Medication". On 12-AUG-2016, the patient was vaccinated with ZOSTAVAX subcutaneous injection (lot #, expiration date, strength, dose and frequency were unknown), subcutaneously. On approximately 16-AUG-2016, about 4 days after receiving ZOSTAVAX, the patient experienced headache and hot, red spot. On 17-AUG-2016, 5 days after receiving ZOSTAVAX, the patient had severe back, leg and thigh pain. The patient did not seek medical attention, and no treatment was given for the events. No lab diagnostics studies were performed. At the time of reporting, the patient was recovering from the events. No product quality complaint (PQC) was involved. The causal relationship between the events and ZOSTAVAX was not provided. Additional information has been requested.
Information has been received from a licensed practical nurse, concerning a 74 year old female patient, who had been vaccinated 10 years prior with a dose of PNEUMOVAX, and on 21-SEP-2007 was vaccinated IM in the left arm with a second dose, 0.5ml, of PNEUMOVAX (lot #657525/0554U).  Concomitant therapy at the visit, included an IM vaccination in the left arm of FLUZONE.  The nurse stated that following the vaccination with PNEUMOVAX, the patient "developed adverse symptoms" described as immediate redness, swelling and soreness at the injection site, as well as a headache.  At the time of this report, the patient had not recovered.  This is one of two reports received from the same source (WAES #0709USA03759) following vaccination with PNEUMOVAX (lot #657525/0554U).  The nurse requested a lot check.  The records of testing prior to release of the lot in question, have been rechecked and found to be satisfactory.  The lot complies with the standards of the research center and was released.  Additional information has been requested.
Information has been received from a consumer concerning her daughter with a history of bronchiolitis on 18-May-2001 (WAES #01120973), a diagnosis of failure to thrive and no drug allergies who in approximately 2001 was vaccinated PO with a dose of Rotateq.  In approximately 2001 "within a week of receiving the vaccine," (It was noted that the patient participated in a clinical trial for Rotateq and was not sure if her daughter received the placebo or the vaccine.) the patient experienced diarrhea on and off.  Medical attention was sought through a physician.  No labs or diagnostic studies were performed.  The patient's outcome was not recovered.  There was no product quality complaint.  Additional information has been requested.
3 days of virtually non-stop crying p/DTP/OPV #2 given; No tx other than APAP; Mom did not notify MD until next visit on 27SEP91;
After a week after the vaccine, I had pain lifting my arm. It was within the arm vaccinated above the elbow. January 10th, I went to the doctor they did an MRI and X-ray to figure out what was going on. He said I might I have SIRVA.
Narrative:  Patient reported headache following administration of 2nd dose of pfizer vaccine. Patient released without intervention.
This spontaneous report as received from a certified medical assistant (C.M.A.) refers to an unspecified number of patients of unknown age and gender. Medical history and drug reactions were not reported. On unknown dates, the patients were vaccinated with improperly stored doses of RECOMBIVAX HB (lot# K021444, expiration date 17-SEP-2016, dose, frequency and route of administration were not reported). Concomitant medication was not provided. No adverse effects were reported. Product quality complaint (PQC) was not involved. This is one of several reports received from the same reporter. Additional information has been requested.
Pain and stiffness in left arm; Stiffness in left arm; General malaise; This case was reported by a consumer and described the occurrence of pain in arm in a 53-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent 2020-2021 season) for prophylaxis.   On 16th October 2020, the patient received Shingrix and Influenza vaccine Quadrivalent 2020-2021 season. In October 2020, less than a week after receiving Shingrix and not applicable after receiving Influenza vaccine Quadrivalent 2020-2021 season, the patient experienced pain in arm, limbs stiffness and general malaise. On 19th October 2020, the outcome of the pain in arm, limbs stiffness and general malaise were recovered/resolved.   It was unknown if the reporter considered the pain in arm, limbs stiffness and general malaise to be related to Shingrix. It was unknown if the reporter considered the general malaise to be related to Influenza vaccine Quadrivalent 2020-2021 season.  Additional details were provided as follows: The age at vaccination was not reported. The patient received Shingrix and Influenza vaccine Quadrivalent 2020-2021 season and experienced pain in arm, limbs stiffness and general malaise, which was recovered. The patient had pain and stiffness in left arm and general malaise for 2 days. No limitations to normal activities.  The reporter consented to follow up. No further information was available.
light headed, sleepy, muscle twitching, fainted. Monitored and resolved in 60 min.
Information has been received from a registered nurse referring to a patient of unknown age and gender. There was no pertinent medical history, concomitant medication or drug allergies/drug reactions reported. On 12-AUG-2015, the patient was vaccinated with ZOSTAVAX (0.5 ml, Lot # L011529, expiration date: 03-JUL-2016), which was improperly stored for 9 days. The outcome was unknown. This is one of several reports received from the same reporter. Additional information has been requested.
Started feeling nauseous and having body aches and chills these symptoms stopped 12/17/2012; site of injection became very sore and inflamed. Went to urgent care 12/18/2012 12:00pm was diagnosed with cellulitis and an abscess at site of injection. I was prescribed Doxycycline 100mg 2xs a day for 10 days. Followed up with Primary care Dec 19th 2:00pm was told to continue antibiotics and to come back in 5 days to see if they helped. Followed up with Primary care Dec 24th 8:00am and the cellulitis was clearing and abscess went down a significant amount. No further action was required.
10/7: Awakened with lower arm pain. 10/8: lower arm swelling with redness and increased heat also red, splotchy area over injection site in upper left arm (deltoid). Saw private MD who stated probably allergy reaction and prescribed prednisone.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. No information was provided regarding concomitant medications, concurrent conditions or medical history. In 2006, the patient was inoculated with the ZOSTAVAX vaccine at a health department as recommended for routine adult health maintenance for the prevention of shingles (dose, route, and lot # not provided). The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain of herpes zoster. In 2013, she was treated by a physician for a vesicular outbreak, which was diagnosed as herpes zoster, or shingles. As a direct and proximate result of ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. Causality assessment was related. Additional information has been requested.
Information has been received from a health professional concerning a 20 year old female who on 17-JAN-2008 was vaccinated with a fourth dose of Gardasil (lot # not reported). The reporter reported that the patient almost fainted and was not feeling well. She was not taken to hospital and she felt better. It was reported that patient got a fourth injection of Gardasil. Additional information has been requested.
Mother reported to clinic with child on morning of 9/12/08.  Complained of rash to sites where vaccines were administered on 9/11/08.  Fine rash noted to left deltoid area and right arm.  Child and mother denied itching.  No fever.
Sx's started @ 15:40 with: hot flashes, shortness of breath/dyspnea, malaise, rash on neck, h/a, and pain in jaw.. Pt reported to ED, was given following Tx: @1723 diphenhydramine IVP 25mg, @1724 SOLU-MEDROL IVP 125mg, @1823 NS 1000mL bolus. Pt was discharged @ 1935.
Pt was given vaccine past the expiration date. Vaccine given on 9/6/2022. Vaccines expired 8/31/2022.
Patient was being monitored post-vaccine for 30 minutes.  At approximately the end of her monitoring period, the patient C/O of extreme "sleepiness."  Stated it was hard for her to stay awake.  Altered mental status.
Pt was given FLUZONE TIV on 10-14-15, developed fever to 103 for 1.5 days with somnolence. Excessive sleepiness has persisted x 2+ weeks now. Labs and imaging unremarkable. Continues to sleep 14-16 hours per day.
Pt came in 2 days after vaccination. Injection site was dark and tender. Ring formed around injection site (looked like a scar). Pt. complained of neurologic pain radiating down arm and limiting use of arm and hand (Brachial Plexus).